Evidence map›Paper›PMID 31023446›Full record

ReviewAdvances in chronic kidney disease2019

Inflammation, Immunity, and Oxidative Stress in Hypertension-Partners in Crime?

Ian R Barrows, Ali Ramezani, Dominic S Raj

Abstract readReview
In one paragraph

Review in Advances in chronic kidney disease, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed, 1 pooled it
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 1 synthesis or guideline pooled it, 111 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. International journal of medical sciences · 2025
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Ian R BarrowsDepartment of Medicine, Georgetown University School of Medicine, Washington, DC; Division of Kidney Diseases and Hypertension, George Washington University School of Medicine, Washington, DC.
Ali RamezaniDepartment of Medicine, Georgetown University School of Medicine, Washington, DC; Division of Kidney Diseases and Hypertension, George Washington University School of Medicine, Washington, DC.
Dominic S RajDepartment of Medicine, Georgetown University School of Medicine, Washington, DC; Division of Kidney Diseases and Hypertension, George Washington University School of Medicine, Washington, DC. Electronic address: draj@mfa.gwu.edu.
George Washington University · USGeorgetown University · US

Funding

Gut Microbiota and Atherosclerosis in ESRDU01DK099914 · NIDDK · GEORGE WASHINGTON UNIVERSITY · PI RAJ, DOMINIC S · 2013 to 2017
$1.9M
Anti-inflammatory Therapy in Diabetic CKDU01DK099924 · NIDDK · GEORGE WASHINGTON UNIVERSITY · PI RAJ, DOMINIC S · 2013 to 2018
$1.8M
NIDDK NIH HHS U01 DK099914NIDDK NIH HHS U01 DK099924
6 · The paper itself

Abstract

Hypertension is considered as the most common risk factor for cardiovascular disease. Inflammatory processes link hypertension and cardiovascular disease, and participate in their pathophysiology. In recent years, there has been an increase in research focused on unraveling the role of inflammation and immune activation in development and maintenance of hypertension. Although inflammation is known to be associated with hypertension, whether inflammation is a cause or effect of hypertension remains to be elucidated. This review describes the recent studies that link inflammation and hypertension and demonstrate the involvement of oxidative stress and endothelial dysfunction-two of the key processes in the development of hypertension. Etiology of hypertension, including novel immune cell subtypes, cytokines, toll-like receptors, inflammasomes, and gut microbiome, found to be associated with inflammation and hypertension are summarized and discussed. Most recent findings in this field are presented with special emphasis on potential of anti-inflammatory drugs and statins for treatment of hypertension.

Indexed as

Anti-Inflammatory AgentsCytokinesEndothelium, VascularGastrointestinal MicrobiomeHumansHydroxymethylglutaryl-CoA Reductase InhibitorsHypertensionInflammasomesInflammationMacrophagesMonocytesNitric OxideOxidative StressReactive Oxygen SpeciesT-LymphocytesToll-Like ReceptorsAnti-Inflammatory AgentsCytokinesHydroxymethylglutaryl-CoA Reductase InhibitorsInflammasomesNitric OxideReactive Oxygen SpeciesToll-Like ReceptorsAnti-inflammatory drugsHypertensionImmune activationInflammationOxidative stress

Identifiers

PMID31023446
PMCPMC6816256
OpenAlexW2941799417

What OpenQuestion holds

Texttitle and abstract
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.